1. Home
  2. EXOZ vs SRZN Comparison

EXOZ vs SRZN Comparison

Compare EXOZ & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXOZ
  • SRZN
  • Stock Information
  • Founded
  • EXOZ 2014
  • SRZN 2015
  • Country
  • EXOZ United States
  • SRZN United States
  • Employees
  • EXOZ N/A
  • SRZN N/A
  • Industry
  • EXOZ
  • SRZN Medicinal Chemicals and Botanical Products
  • Sector
  • EXOZ
  • SRZN Health Care
  • Exchange
  • EXOZ NYSE
  • SRZN Nasdaq
  • Market Cap
  • EXOZ 89.8M
  • SRZN 72.8M
  • IPO Year
  • EXOZ N/A
  • SRZN N/A
  • Fundamental
  • Price
  • EXOZ $9.98
  • SRZN $8.95
  • Analyst Decision
  • EXOZ
  • SRZN Strong Buy
  • Analyst Count
  • EXOZ 0
  • SRZN 2
  • Target Price
  • EXOZ N/A
  • SRZN $38.50
  • AVG Volume (30 Days)
  • EXOZ 7.9K
  • SRZN 13.0K
  • Earning Date
  • EXOZ 08-15-2025
  • SRZN 08-11-2025
  • Dividend Yield
  • EXOZ N/A
  • SRZN N/A
  • EPS Growth
  • EXOZ N/A
  • SRZN N/A
  • EPS
  • EXOZ N/A
  • SRZN N/A
  • Revenue
  • EXOZ N/A
  • SRZN $11,638,000.00
  • Revenue This Year
  • EXOZ N/A
  • SRZN N/A
  • Revenue Next Year
  • EXOZ N/A
  • SRZN N/A
  • P/E Ratio
  • EXOZ N/A
  • SRZN N/A
  • Revenue Growth
  • EXOZ N/A
  • SRZN N/A
  • 52 Week Low
  • EXOZ $8.50
  • SRZN $5.90
  • 52 Week High
  • EXOZ $23.99
  • SRZN $18.17
  • Technical
  • Relative Strength Index (RSI)
  • EXOZ N/A
  • SRZN 55.82
  • Support Level
  • EXOZ N/A
  • SRZN $8.20
  • Resistance Level
  • EXOZ N/A
  • SRZN $8.94
  • Average True Range (ATR)
  • EXOZ 0.00
  • SRZN 0.46
  • MACD
  • EXOZ 0.00
  • SRZN 0.05
  • Stochastic Oscillator
  • EXOZ 0.00
  • SRZN 96.15

About EXOZ EXOZYMES INC

EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.

About SRZN Surrozen Inc.

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Share on Social Networks: